Hyloris Pharmaceuticals Eulerpool Novinky

Hyloris Pharmaceuticals Eulerpool News

Hyloris Pharmaceuticals Novinky o akciích

Hyloris Pharmaceuticals je sledován mnoha novináři a investory po celém světě. Nejaktuálnější Hyloris Pharmaceuticals zprávy shromažďujeme zde.

• 14. března ·

  Yahoo
  Hyloris Reports Full Year Results for 2023 & Provides Business Outlook
• 14. března ·

  Yahoo
  Communication at the request of the FSMA on the transactions with Qliniq
• 8. března ·

  Yahoo
  Hyloris to Report 2023 Full-Year Results on 14 March 2024
• 27. února ·

  Yahoo
  Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada
• 14. února ·

  Yahoo
  Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures
• 30. ledna ·

  Yahoo
  Hyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC)
• 18. ledna ·

  Yahoo
  Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)
• 16. ledna ·

  Yahoo
  Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
• 16. ledna ·

  Yahoo
  Pleco Therapeutics receives FDA Orphan Drug Designation
• 26. prosince ·

  Yahoo
  Hyloris Announces Positive Clinical Study Results for Valacyclovir Oral Suspension (HY-029)